Pre-Market Stock News (MAR 20, 2007)

By Douglas A. McIntyre Published Mar 20, 7:11AM EDT

Follow 24/7 Wall St. on Google

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

(ACS) Affiliated Computer Systems is up on talks being indicated for a merger by Cerberus Capital private equity; indicated up $8.00 to $59.00+.
(ADBE) Adobe reports after the close ($0.29/$655.5M est.).
(ALVR) Alvarion chosen by Enforta for 6 city broadband wireless access solutions.
(BCSI) Bluecoat Systems wins pact from Philips Electronics (China unit).
(CORT) Corcept Therapeutics announced Phase 3 study evaluating CORLUX(R) for Psychotic Major Depression missed its primary endpoint.
(CRZO) Carrizo Oil & Gas $0.18 EPS vs $0.14e.
(CSIQ) Canadian Solar won a contract to supply BIPV solar glass roof system to China’s Luoyang polysilicon company.
(CTIC) Cell Therapeutics files for special protocol assessment for XYOTAX PGT307 lung cancer trial in women.
(ECIL) ECI Telecom said it may see $55M to $70M in gains after completion of the Veraz Networks IPO.
(EW) Edwards Lifesciences received approval to start transcatheter heart valve pivotal trial.
(FDS) Factset $0.49 EPS vs $0.48e; guides slightly higher.
(GNVC) Genvec Signs cooperative R&D agreement with the National Institute of Allergy and Infectious Diseases to develop RSV vaccines.
(ISLN) Isilon Systems won 2 government orders.
(ITMN) Intermune announced $40 to $50 million in operating expense reduction via 50% workforce layoffs.
(JEC) Jacobs Engineering won a $550 Million government contract.
(LB) LaBarge wins $4.4 million order from for mine information systems.
(LEND) Accredited Home Lenders announces $200 million term loan commitment from Farallon Capital Management.
(MOGN) MGI Pharma announces "positive results" from a Pivotal Phase 3 Study of Aquavan for bronchoscopy.
(MYGN) Myriad Genetics announces that it has completed enrollment of patients in its global Phase 3 trial of Flurizan in Alzheimer’s disease.
(ORCL) Oracle reports after the close ($0.23/$4.33B est).
(PALM) Palm is trading up 10% on more talk of a merger offer coming from either Nokia or Motorola.
(PRGS) Progress Software $0.37 EPS vs $0.35e.
(PTIE) Pain Therapeutics said it has been cleared to initiate Phase I study in metastatic melanoma.
(TMIC) Trend Micro will repurchase 1 million shares in the next two weeks.

Jon C. Ogg
March 20, 2007

About the Author Douglas A. McIntyre →

Douglas A. McIntyre is the co-founder, chief executive officer and editor in chief of 24/7 Wall St. and 24/7 Tempo. He has held these jobs since 2006.

McIntyre has written thousands of articles for 24/7 Wall St. He is an expert on corporate finance, the automotive industry, media companies and international finance. He has edited articles on national demographics, sports, personal income and travel.

His work has been quoted or mentioned in The New York Times, The Wall Street Journal, Los Angeles Times, The Washington Post, NBC News, Time, The New Yorker, HuffPost USA Today, Business Insider, Yahoo, AOL, MarketWatch, The Atlantic, Bloomberg, New York Post, Chicago Tribune, Forbes, The Guardian and many other major publications. McIntyre has been a guest on CNBC, the BBC and television and radio stations across the country.

A magna cum laude graduate of Harvard College, McIntyre also was president of The Harvard Advocate. Founded in 1866, the Advocate is the oldest college publication in the United States.

TheStreet.com, Comps.com and Edgar Online are some of the public companies for which McIntyre served on the board of directors. He was a Vicinity Corporation board member when the company was sold to Microsoft in 2002. He served on the audit committees of some of these companies.

McIntyre has been the CEO of FutureSource, a provider of trading terminals and news to commodities and futures traders. He was president of Switchboard, the online phone directory company. He served as chairman and CEO of On2 Technologies, the video compression company that provided video compression software for Adobe’s Flash. Google bought On2 in 2009.